Project Grant R41GM157757
Award Date
6/1/25
Completion Date
5/31/26
Dollars Obligated
$350K
Federal Agency
National Institute of General Medical Sciences
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Emigration Canyon, UT 84108, USA
Similar Awards
This $406,500 Project Grant award from the National Institutes of Health's National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) aims to advance next-generation mass spectrometry-based sequencing (NGMS-SEQ) methods for high-throughput direct sequencing and quantitative mapping of RNA modifications. The award recipient, Directseq Biosciences, Inc., will focus on two key objectives: 1) Improving NGMS-SEQ techniques to enable direct sequencing of various tRNA samples,...
The National Human Genome Research Institute (NHGRI) awarded a $409,699 Project Grant (CFDA 93.172 - Human Genome Research) to the Regents of the University of Michigan on July 1, 2024. The grant, titled "INTEGRATING LC-MS/MS AND NANOPORE SEQUENCING PLATFORMS TO ENABLE THE DIRECT AND QUANTATATIVE DETECTION OF RNA MODIFICATIONS", will support research to develop methods for the quantitative detection of RNA modifications using a combination of liquid chromatography-tandem mass...
This federal Project Grant award, valued at $215,088.00 and made by the National Human Genome Research Institute (NHGRI) under the Human Genome Research (CFDA 93.172) program, supports the development of an innovative "next-generation mass spectrometry-based sequencing (NGMS-SEQ)" method for exhaustive de novo sequencing of all RNA species in a sample. The award aims to 1) further develop the NGMS-SEQ approach to directly identify and sequence every RNA molecule, including...
The National Human Genome Research Institute (NHGRI), under the Federal Grant Program "Human Genome Research" (CFDA 93.172), awarded a $407,291 Phase I Small Business Innovation Research (SBIR) grant to Electronic Biosciences, Inc. to develop a nanopore-based protein sequencing platform. The project aims to create a high-accuracy, label-free nanopore reader capable of direct, single-molecule protein sequencing. This novel technology would enable proteome-wide profiling, biomarker...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under CFDA program 93.859 - Biomedical Research and Research Training provides $787,500.00 to the Regents of the University of California at Riverside to investigate the roles of nuclear RNA modifications in gene regulation. The 5-year award, beginning August 1, 2024, will focus on studying three types of nuclear RNA modifications: 1) the removal of the 5' triphosphate group, 2) the addition of the m2,2,7G...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) provides $204,688 to The Johns Hopkins University to develop innovative sequencing technologies to study DNA ADP-ribosylation, an under-researched DNA modification with critical implications for processes like DNA repair and pathogen defense. The project aims to create two complementary sequencing techniques: one using...
This $256,000 National Science Foundation Engineering grant supports the development of an easy RNA adenylation method for deep sequencing of picogram RNA samples with high resolution. Specifically, Ezrabio Inc. will develop a versatile and cost-effective library construction technology that enables protein translation monitoring on a variety of biological samples. The proposed technology relies on a novel enzyme system capable of 5' adenylation and 3' polyadenylation of RNA fragments to...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $303,445 to Endura Therapeutics Inc. aims to develop a next-generation sequencing platform for discovering small molecules that target RNA. The project addresses two key challenges: demonstrating that small molecules binding to messenger RNA can modulate protein expression in cells, and developing a high-throughput screening method to identify such molecules and their optimal...
The National Cancer Institute (NCI) awarded a $400,000 Project Grant under the Cancer Detection and Diagnosis Research program (CFDA 93.394) to Electronic Biosciences, Inc., a small biotechnology company in San Diego, California. The grant supports the development of a novel nanopore-based sequencing approach to accurately characterize repetitive DNA sequences, which are critical for understanding cancer progression but challenging to analyze using current sequencing-by-synthesis methods. The...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $432,834 to the Board of Regents of the University of Nebraska to develop an "enzyme-free, label-free quantitative microarray technology" for profiling mixtures of approximately 25 microRNA (miRNA) sequences. The goal is to create a "perfect switch" binary probe design that generates a redox signal upon target...